BE641880A - - Google Patents

Info

Publication number
BE641880A
BE641880A BE641880A BE641880A BE641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A
Authority
BE
Belgium
Application number
BE641880A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE641880A publication Critical patent/BE641880A/xx

Links

BE641880A 1962-12-27 1963-12-27 BE641880A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP6427663 1963-10-29
JP5741963 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
BE641880A true BE641880A (cg-RX-API-DMAC10.html) 1964-04-16

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
BE641880A BE641880A (cg-RX-API-DMAC10.html) 1962-12-27 1963-12-27

Country Status (5)

Country Link
BE (1) BE641880A (cg-RX-API-DMAC10.html)
FR (1) FR3150M (cg-RX-API-DMAC10.html)
GB (1) GB1080599A (cg-RX-API-DMAC10.html)
LU (1) LU45106A1 (cg-RX-API-DMAC10.html)
NL (1) NL302572A (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
EA018007B1 (ru) 2004-11-26 2013-04-30 Ю Си Эл БИЗНЕС Пи Эл Си Композиция, содержащая орнитин и фенилацетат или фенилбутират, для лечения печеночной энцефалопатии
KR101975726B1 (ko) 2009-04-03 2019-05-07 오세라 테라퓨틱스, 아이엔씨. L-오르니틴 페닐 아세테이트, 및 이의 제조방법
US20120157526A1 (en) 2009-06-08 2012-06-21 Ucl Business Plc Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
CN103502203B (zh) 2010-10-06 2016-09-07 欧塞拉治疗有限公司 制备l-鸟氨酸苯基乙酸盐的方法
EP3685841A1 (en) 2014-11-24 2020-07-29 Ucl Business Ltd Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
CA2995823A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
WO2018208677A1 (en) 2017-05-11 2018-11-15 Ocera Therapeutics, Inc. Processes of making l-ornithine phenylacetate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
GB1080599A (en) 1967-08-23
LU45106A1 (cg-RX-API-DMAC10.html) 1964-02-24
NL302572A (cg-RX-API-DMAC10.html)
FR3150M (fr) 1965-02-22

Similar Documents

Publication Publication Date Title
BE616548R (cg-RX-API-DMAC10.html)
BE628342A (cg-RX-API-DMAC10.html)
BE612190A (cg-RX-API-DMAC10.html)
LU45106A1 (cg-RX-API-DMAC10.html)
BE614566A (cg-RX-API-DMAC10.html)
BE635203A (cg-RX-API-DMAC10.html)
BE631700A (cg-RX-API-DMAC10.html)
BE614532A (cg-RX-API-DMAC10.html)
BE614432A (cg-RX-API-DMAC10.html)
BE631659A (cg-RX-API-DMAC10.html)
BE631152A (cg-RX-API-DMAC10.html)
BE614403A (cg-RX-API-DMAC10.html)
BE614380A (cg-RX-API-DMAC10.html)
BE614159A (cg-RX-API-DMAC10.html)
BE613862A (cg-RX-API-DMAC10.html)
BE629571A (cg-RX-API-DMAC10.html)
BE613529A (cg-RX-API-DMAC10.html)
BE629479A (cg-RX-API-DMAC10.html)
BE613335A (cg-RX-API-DMAC10.html)
BE613319A (cg-RX-API-DMAC10.html)
BE613298A (cg-RX-API-DMAC10.html)
BE629198A (cg-RX-API-DMAC10.html)
BE613190A (cg-RX-API-DMAC10.html)
BE380301A (cg-RX-API-DMAC10.html)
BE614739A (cg-RX-API-DMAC10.html)